HomeGUD • TSE
add
Knight Therapeutics Inc
Previous close
$5.94
Day range
$5.92 - $6.01
Year range
$5.11 - $6.55
Market cap
587.62M CAD
Avg Volume
50.82K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 121.55M | 31.74% |
Operating expense | 55.16M | 31.93% |
Net income | -3.79M | -4,560.00% |
Net profit margin | -3.12 | -3,566.67% |
Earnings per share | -0.02 | — |
EBITDA | 18.41M | 10.98% |
Effective tax rate | -97.76% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 118.14M | -31.44% |
Total assets | 1.05B | 8.97% |
Total liabilities | 281.78M | 49.58% |
Total equity | 766.79M | — |
Shares outstanding | 99.29M | — |
Price to book | 0.77 | — |
Return on assets | 0.15% | — |
Return on capital | 0.19% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.79M | -4,560.00% |
Cash from operations | 10.16M | 102.61% |
Cash from investing | -1.41M | -112.20% |
Cash from financing | -5.91M | -50.47% |
Net change in cash | 4.06M | -68.64% |
Free cash flow | -3.92M | -484.53% |
About
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Founded
2014
Headquarters
Website
Employees
745
